Pinnacle Financial Group, Inc.’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.14K Buy
+9,932
New +$10.7K ﹤0.01% 1626

Other funds holding AKBA

Pinnacle Financial Group, Inc.'s AKBA Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Akebia Therapeutics (AKBA) in Q3 2026: 9,932 shares worth $9.14K. The stake represents ﹤0.01% of the portfolio and ranks #1626 among its holdings.

156 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 9,932 shares of Akebia Therapeutics worth $9.14K as of Q3 2026.
  • Akebia Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Akebia Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1626 holding.
  • 156 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.